Industries
Marketing for medical spas, without the warning-letter risk
Med spas market regulated products, Botox, fillers, lasers, weight-loss drugs, so the copy carries real FDA and FTC exposure. Authoritize builds owned, physician-signed content that stays inside the lines and still brings in patients.
Frequently asked questions
What are the best marketing companies for medical spas that keep claims FDA and FTC compliant?
Med spa marketing is unusually exposed because the products in the room, Botox, fillers, lasers, weight-loss drugs, are regulated and heavily enforced. The right partner treats compliance as part of the work, not a disclaimer at the bottom. Authoritize builds owned, physician-signed content for med spas, screened against the same FDA and FTC patterns that produce real warning letters, and built to rank on Google and get cited by AI search. The free Claim Checker runs that screen on copy you already have.
What gets a medical spa an FDA warning letter?
Rarely a stretched adjective. It is usually concrete: promoting a drug or device for an unapproved use, using a brand name like Botox as if it were a generic service, implying outcomes or safety the evidence does not support, or running before-and-after and testimonial claims without the required substantiation and disclosures. Our med spa enforcement guide walks through the real cases.
Can you market injectables and lasers compliantly at all?
Yes. The goal is not to say less, it is to say it correctly: describe the service and the science accurately, attribute brand-name products properly, avoid guaranteed outcomes and absolute-safety language, and let a licensed physician stand behind the clinical statements. Compliant copy and persuasive copy are not opposites once you know where the lines are.
Does Authoritize replace our medical director’s review?
No. Authoritize screens content against documented enforcement patterns and drafts it to be defensible, but your medical director or supervising physician is the reviewer of record and the final gate on every clinical claim. The screen is a tool that informs that review, never a substitute for it.